Literature DB >> 26470898

Radiation Therapy in the Management of Malignant Melanoma.

Anand Mahadevan, Vivek L Patel, Nergiz Dagoglu.   

Abstract

The initial treatment for primary and locoregional melanoma is surgery. Systemic therapy, and more recently immune therapy, has been the mainstay in the adjuvant and particularly the metastatic setting. Aside from palliation, there is a limited role for definitive radiation therapy for melanoma. However, in the adjuvant setting, postoperative radiation can improve locoregional disease control, albeit with potential toxicity and limited survival benefit. Stereotactic radiosurgery plays a vital role in the treatment of limited brain and extracranial metastasis.

Entities:  

Mesh:

Year:  2015        PMID: 26470898

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  10 in total

1.  The effectiveness and safety of X-PDT for cutaneous squamous cell carcinoma and melanoma.

Authors:  Lei Shi; Pei Liu; Jing Wu; Lun Ma; Han Zheng; Michael P Antosh; Haiyan Zhang; Bo Wang; Wei Chen; Xiuli Wang
Journal:  Nanomedicine (Lond)       Date:  2019-06-05       Impact factor: 5.307

2.  Consensus Guidelines for the Management of Melanoma during the COVID-19 Pandemic: Surgery, Systemic Anti-cancer Therapy, Radiotherapy and Follow-up.

Authors:  S H Nahm; A Rembielak; H Peach; P C Lorigan
Journal:  Clin Oncol (R Coll Radiol)       Date:  2020-07-01       Impact factor: 4.126

3.  Twice-daily Radiation for Metastatic Malignant Melanoma: A Different Approach Resulting in a Significant Response.

Authors:  Norman H Anderson; Julie B Arcaro
Journal:  Cureus       Date:  2019-03-01

4.  Inhibitory Effects of Ginsenoside Ro on the Growth of B16F10 Melanoma via Its Metabolites.

Authors:  Si-Wen Zheng; Sheng-Yuan Xiao; Jia Wang; Wei Hou; Ying-Ping Wang
Journal:  Molecules       Date:  2019-08-17       Impact factor: 4.411

5.  Long noncoding RNA LINC00518 induces radioresistance by regulating glycolysis through an miR-33a-3p/HIF-1α negative feedback loop in melanoma.

Authors:  Yan Liu; Dong He; Mengqing Xiao; Yuxing Zhu; Jianda Zhou; Ke Cao
Journal:  Cell Death Dis       Date:  2021-03-04       Impact factor: 8.469

Review 6.  Pulmonary metastatic melanoma: current state of diagnostic imaging and treatments.

Authors:  Kermit S Zhang; Tomer Pelleg; Sabrina Campbell; Catalina Rubio; Anthony Lukas Loschner; Susanti Ie
Journal:  Melanoma Manag       Date:  2021-07-09

Review 7.  ROS Pleiotropy in Melanoma and Local Therapy with Physical Modalities.

Authors:  Sanjeev Kumar Sagwal; Sander Bekeschus
Journal:  Oxid Med Cell Longev       Date:  2021-11-03       Impact factor: 6.543

8.  The effect of local non-thermal plasma therapy on the cancer-immunity cycle in a melanoma mouse model.

Authors:  Abraham Lin; Joey De Backer; Delphine Quatannens; Bart Cuypers; Hanne Verswyvel; Edgar Cardenas De La Hoz; Bart Ribbens; Vasiliki Siozopoulou; Jonas Van Audenaerde; Elly Marcq; Filip Lardon; Kris Laukens; Steve Vanlanduit; Evelien Smits; Annemie Bogaerts
Journal:  Bioeng Transl Med       Date:  2022-04-21

9.  Collective cancer invasion forms an integrin-dependent radioresistant niche.

Authors:  Anna Haeger; Stephanie Alexander; Manon Vullings; Fabian M P Kaiser; Cornelia Veelken; Uta Flucke; Gudrun E Koehl; Markus Hirschberg; Michael Flentje; Robert M Hoffman; Edward K Geissler; Stephan Kissler; Peter Friedl
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

10.  Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients.

Authors:  Aglaia Schiza; Sandra Irenaeus; Francisco Ortiz-Nieto; Angelica Loskog; Thomas Tötterman; Anders Sundin; Gustav J Ullenhag; Håkan Ahlström
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.